Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents.
Majithia N, Rajkumar SV, Lacy MQ, Buadi FK, Dispenzieri A, Gertz MA, Hayman SR, Dingli D, Kapoor P, Hwa L, Lust JA, Russell SJ, Go RS, Kyle RA, Kumar SK.
Majithia N, et al. Among authors: kumar sk.
Leukemia. 2016 Nov;30(11):2208-2213. doi: 10.1038/leu.2016.147. Epub 2016 May 23.
Leukemia. 2016.
PMID: 27211270
Free PMC article.